150 Immediate results of percutaneous mitral commissurotomy (Experience of Center of cardiology-University Hospital Ibn Rochd-Casablanca-Morocco)  by Wadrahmane, Fatima et al.
 © Elsevier Masson SAS. All rights reserved.
 
 
Archives of Cardiovascular Diseases Supplements (2011) 3, 45-54 49
 
150
 
Immediate results of percutaneous mitral commissurotomy
(Experience of Center of cardiology- University Hospital Ibn Rochd-
Casablanca-Morocco)
Fatima Wadrahmane, Roger Kongo Minga, Farah Korchi
CHU Ibn Rochd Casablanca, Cardiologie, Casablanca, Maroc
In developing countries mitral stenosis is a frequent heart disease. The ther-
apeutic management of mitral stenosis has been substantially improved
through the development of percutaneous mitral commissurotomy, whose
safety and efficacy have been demonstrated in many studies.
The aim of this work is to study the immediate results of percutaneous mitral
commissurotomy (PMC) in patients with severe mitral stenosis managed in
Center of cardiology- University Hospital IBN Rochd-Casablanca.
Of 150 patients there were 20 men and 130 women including 10 pregnant
women (third trimester of pregnancy), their mean age was 35 ± 10 years. One
hundred were in NYHA  class II, 40 in class III and 10 in class IV. Eighty
patients with atrial fibrillation.
All patients had transthoracic echocardiography before and after the proce-
dure and transesophageal echocardiography before the PMC. Wilkins score
calculated in all patients with an average 7 ± 4. Grade 1+ mitral regurgitation
was present in 70 and grade 2+ in 13. Mitral regurgitation grade I or II devel-
oped in 8 patients. The PMC was converted into a mitral replacement surgery
in one patient. Tamponade occurred in one patient. No patient died.
Mitral surface area and hemodynamic parameters improved significantly
after PMC; mean left atrial pressure fell from 18.76 ± 6.18 to 10.65 ± 4.38
mmHg (P < 0.001), mean transmitral gradient from 14.03 ± 4.70 to 4.63 ±
2.05mmHg (p < 0.001) and mitral valve area from 0.99 ± 0.22 to 1.88 ±
0.41cm2 (p < 0.001).
In conclusion, PMC is a safe and effective treatment in a wide range of
patients with mitral stenosis.
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Rationale:
 
 In pulmonary arterial hypertension (PAH),  the raise of vascular
resistance lead to right ventricular dysfunction, fluid retention and death. In
this setting, we evaluated the determinants of moderate renal dysfunction and
its impact on mortality.
 
Materiel and methods:
 
 38 consecutive PAH patients were prospectively
enrolled. Right ventricular dysfunction was assessed by echocardiography
using two-dimensional strain, tissue Doppler imaging and  tricuspid annular
displacement (TAPSE). Right-sided catheterism, 6-minute walking distance
and biological sampling was performed within 48 hours. Moderate Renal dys-
function was defined by a creatinine clearance below 60 ml/min. 
 
Results:
 
 In the overall cohort, renal dysfunction was associated with
decreased cardiac output, SVO
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, TAPSE, haemoglobin levels, 6 min walking
distance  and increased BNP levels. By univariate analysis, predictors of mor-
tality were TAPSE < 15 mm (OR: 10.25 95% CI [1.06-29.44]; p = 0.028),
BMI < 25 kg/m
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 (OR: 5.00 95% CI [1.04-23.84]; p = 0.043) and renal dys-
function (OR: 9.43 95% CI [1.96-45.29]; p = 0.005). By multivariate analysis,
renal dysfunction remains the sole independent predictor of mortality at one
year follow-up (OR: 5.597 95% CI [1.064-29.441]; p = 0.042).
 
Conclusion:
 
 Moderate renal dysfunction is a powerfull marker of prog-
nosis in PAH.
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severity. Clinical implications. 
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Background:  
 
Recent studies have emphasized the importance of quantita-
tive assessment of valvular regurgitation.  However, in clinical practice mainly
semi-quantitative methods remain used despite an unclear diagnostic value.
We aimed to define the sensitivity and specificity of semi-quantitative
methods compared to the PISA for the diagnostic of severe aortic regurgitation
(AR). 
 
Methods:
 
 Degree of AR was prospectively evaluated using the PISA
method and 4 semi-quantitative measurements (cardiac output (CO), pressure
half time (PHT), vena contracta (VC) and diastolic flow reversal (DFR)) in
224 patients with a wide range of AR severity. Criteria for severe AR were an
ERO 30mm
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, a CO  10 l/min, a PHT < 200ms, a VC  6 mm or a DFR  18 cm/
s. 
Left atrium variables Before BMV After BMV 1 month after 
BMV
p value (before vs 
after)
p value (before vs at 
1 month
Volume, mL 77±22 66±18 62±18 0.0003 <0.0001
Indexed volume, mL/m2 56±14 48±12 45±13 0.0002 <0.0001
Anteroposterior diameter, mm 44±5 41±5 40±6 <0.0001 <0.0001
Inferosuperior diameter, mm 67±6 66±6 65±6 0.5 0.07
Mediolateral diameter, mm 48±6 45±5 45±4 0.02 0.007
Area, cm2 27±5 25±4 25±4 0.02 0.003
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